YIELD10 BIOSCIENCE, INC.: Nasdaq/NYSE listing notice — Yield10 Bioscience granted Nasdaq extension until May 13, 2024, subject to conditions

YIELD10 BIOSCIENCE, INC.

Panel granted extension to May 13, 2024, after Feb 6 hearing; conditions include a written financing update by Mar 15.
Company remains non-compliant with minimum stockholders' equity and $1.00 bid price requirements on Nasdaq.
Bid price compliance period ends Mar 25, 2024; may seek additional 180-day period if not met.
No assurance that Yield10 can satisfy ongoing listing criteria during the extension period.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

YIELD10 BIOSCIENCE, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

September 25, 2023, Yield10 received a deficiency letter from the Staff notifying the Company that it was not in compliance with the requirement to maintain a minimum bid price of at least $1.00 per share pursuant to Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until March 25, 2024, to regain compliance with this listing requirement. To regain compliance, the closing bid price of the Company’s common stock must be $1.00 per share or more for a minimum of 10 consecutive business day

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

YIELD10 BIOSCIENCE, INC. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: extension granted
Deficiency: stockholders equity
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

nce with Nasdaq requirements. Also as previously disclosed, on September 25, 2023, Yield10 received a deficiency letter from the Staff notifying the Company that it was not in compliance with the requirement to maintain a minimum bid price of at least $1.00 per share pursuant to Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until March 25, 2024, to regain compliance with this listing requirement. To regain compliance, the closing bid price of the Company’s common stock must be $1.00

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001121702-24-000012

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.